Wellington Management Group’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-37,029
Closed -$2.52M 2197
2022
Q3
$2.52M Sell
37,029
-564,952
-94% -$38.5M ﹤0.01% 1467
2022
Q2
$19.2M Buy
601,981
+567,120
+1,627% +$18.1M ﹤0.01% 956
2022
Q1
$1.21M Sell
34,861
-7,245
-17% -$251K ﹤0.01% 1706
2021
Q4
$1.23M Buy
42,106
+970
+2% +$28.4K ﹤0.01% 1769
2021
Q3
$1.05M Sell
41,136
-1,393,591
-97% -$35.5M ﹤0.01% 1790
2021
Q2
$50.2M Sell
1,434,727
-289,401
-17% -$10.1M 0.01% 825
2021
Q1
$70.3M Sell
1,724,128
-313,992
-15% -$12.8M 0.01% 712
2020
Q4
$88.3M Sell
2,038,120
-220,075
-10% -$9.53M 0.02% 623
2020
Q3
$125M Sell
2,258,195
-146,855
-6% -$8.1M 0.03% 477
2020
Q2
$152M Sell
2,405,050
-359,214
-13% -$22.7M 0.03% 420
2020
Q1
$141M Sell
2,764,264
-130,221
-4% -$6.65M 0.04% 387
2019
Q4
$230M Sell
2,894,485
-906,877
-24% -$72.1M 0.05% 365
2019
Q3
$184M Buy
3,801,362
+248,068
+7% +$12M 0.04% 403
2019
Q2
$187M Sell
3,553,294
-48,976
-1% -$2.58M 0.04% 385
2019
Q1
$191M Sell
3,602,270
-91,418
-2% -$4.84M 0.04% 379
2018
Q4
$152M Sell
3,693,688
-146,222
-4% -$6M 0.04% 395
2018
Q3
$146M Sell
3,839,910
-176,513
-4% -$6.71M 0.03% 466
2018
Q2
$182M Sell
4,016,423
-324,768
-7% -$14.7M 0.04% 400
2018
Q1
$210M Buy
4,341,191
+2,214,424
+104% +$107M 0.05% 366
2017
Q4
$83.7M Sell
2,126,767
-341,226
-14% -$13.4M 0.02% 622
2017
Q3
$76.6M Buy
2,467,993
+119,137
+5% +$3.7M 0.02% 626
2017
Q2
$64.2M Buy
2,348,856
+27,733
+1% +$759K 0.02% 656
2017
Q1
$85.5M Buy
2,321,123
+225,994
+11% +$8.33M 0.02% 565
2016
Q4
$30.3M Sell
2,095,129
-70,382
-3% -$1.02M 0.01% 866
2016
Q3
$49.9M Buy
2,165,511
+545,465
+34% +$12.6M 0.01% 695
2016
Q2
$26.9M Buy
1,620,046
+1,197,490
+283% +$19.9M 0.01% 853
2016
Q1
$6.7M Sell
422,556
-577,946
-58% -$9.17M ﹤0.01% 1265
2015
Q4
$32.3M Buy
1,000,502
+314,788
+46% +$10.2M 0.01% 811
2015
Q3
$28.3M Buy
+685,714
New +$28.3M 0.01% 853